A pilot phase II trial of cabazitaxel in patients with metastatic NSCLC progressing after docetaxel-based treatment
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Sep 2016 Efficacy and safety results (n=46) published in the British Journal of Cancer.
- 25 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 23 Jun 2014 Planned End Date changed from 1 Mar 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.